Fingerprint
Dive into the research topics of 'High-dose recombinant interleukin-2 alone: A regimen with limited activity in the treatment of advanced renal cell carcinoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
High-dose recombinant interleukin-2 alone: A regimen with limited activity in the treatment of advanced renal cell carcinoma
Jeffrey S. Abrams, Anthony A. Rayner, Peter H. Wiernik, David R. Parkinson, Mario Eisenberger, Frederick R. Aronson, Rasim Gucalp, Michael B. Atkins, Michael J. Hawkins
Research output: Contribution to journal › Article › peer-review
61
Scopus
citations